AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 129 filers reported holding AMPIO PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,452,000 | -62.2% | 24,000 | 0.0% | 0.00% | -100.0% |
| Q2 2022 | $3,840,000 | -66.0% | 24,000 | 0.0% | 0.00% | -66.7% |
| Q1 2022 | $11,280,000 | -17.5% | 24,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $13,680,000 | -65.7% | 24,000 | 0.0% | 0.00% | -70.0% |
| Q3 2021 | $39,840,000 | -1.8% | 24,000 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $40,560,000 | -8.6% | 24,000 | 0.0% | 0.01% | -9.1% |
| Q1 2021 | $44,400,000 | +16.4% | 24,000 | 0.0% | 0.01% | +10.0% |
| Q4 2020 | $38,160,000 | +66.1% | 24,000 | 0.0% | 0.01% | +42.9% |
| Q3 2020 | $22,968,000 | +50.3% | 24,000 | 0.0% | 0.01% | +40.0% |
| Q2 2020 | $15,286,000 | +20.2% | 24,000 | 0.0% | 0.01% | 0.0% |
| Q1 2020 | $12,720,000 | -24.4% | 24,000 | 0.0% | 0.01% | 0.0% |
| Q4 2019 | $16,824,000 | – | 24,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,595,484 | $10,564,000 | 9.31% |
| Cypress Capital Management LLC (WY) | 108,400 | $441,000 | 0.50% |
| Noven Financial Group, Inc. | 158,059 | $643,000 | 0.37% |
| Transform Wealth, LLC | 205,481 | $836,000 | 0.15% |
| GHP Investment Advisors, Inc. | 100,000 | $407,000 | 0.06% |
| Pratt Collard Advisory Partners LLC | 15,600 | $63,000 | 0.05% |
| JANICZEK WEALTH MANAGEMENT, LLC | 16,719 | $68,000 | 0.04% |
| Virtu Financial LLC | 92,344 | $376,000 | 0.02% |
| JFS WEALTH ADVISORS, LLC | 18,150 | $74,000 | 0.02% |
| CONDOR CAPITAL MANAGEMENT | 21,400 | $87,000 | 0.02% |